SS&C Intralinks Success Stories

We’ve helped clients in nearly every country and industry throughout the world with secure innovative, productivity-driving solutions for high-value M&A, debt capital markets and banking transactions.

Here are just a few of our recent success stories. We’d love to add your brand to our hall of fame.

North Haven Real Estate Fund X Global​

USD 3.1 billion​

North Haven Real Estate Fund X Global​
North Haven Real Estate Fund X Global is an opportunistic fund investing on a global basis. The private fund targets cash-flow generating assets that offer high yields and long-dated income.​
Oriens Capital Private Equity Fund 2​

USD 100 million​

Oriens Capital Private Equity Fund 2​
Oriens Capital Private Equity Fund 2 is the second fund in its series. The fund focuses on mid-market opportunities in regional New Zealand. ​
Ronin Fund I​

USD 300 million​

Ronin Fund I​
Ronin Fund I invests in the industrial, consumer and TMT sectors throughout North America. The fund is managed by Ronin Equity Partners.​
Shore Capital Business Services Partners Fund I​

USD 213 million​

Shore Capital Business Services Partners Fund I​
Shore Capital Business Services Partners Fund I is a buyout fund that focuses on business services industries across the US..​
Siguler Guff Global Emerging Markets Co-Investment Fund​

USD 240 million​

Siguler Guff Global Emerging Markets Co-Investment Fund​
The Siguler Guff Global Emerging Markets Co-Investment Fund will seek to build a diversified portfolio of investments in leading companies that are based in or utilize talents and expertise in the emerging markets.​
SkyKnight Capital Fund III​

USD 600 million​

SkyKnight Capital Fund III​
SkyKnight Capital Fund III is a mezzanine fund managed by SkyKnight Capital that invests in minority and "small majority" businesses, focuses on healthcare, insurance and tech enabled services.​
Starwood Distressed Opportunity Fund XII​

USD 10 billion​

Starwood Distressed Opportunity Fund XII​
Starwood Distressed Opportunity Fund XII pursues an opportunistic real estate strategy across Europe, the United States, Asia and Australia​
Town Hall Ventures II​

USD 270 million​

Town Hall Ventures II​
Town Hall Ventures II applies a stage agnostic approach to investing in health care technology and services businesses across the United States.​
True Wind Fund II​

USD 817 million​

True Wind Fund II​
True Wind Fund II is a buyout fund that focuses on investing in the US technology sector.​

USD 825 million​

Vida Ventures III​
Vida Ventures III is a fund managed by Vida Ventures. The fund invests in healthcare, biotechnology, and pharmaceuticals.​

USD 850 million​

VMG Partners V​
VMG Partners V invests in entrepreneurial early and late stage consumer focused companies across the US.​
Whitehorse Liquidity Partners IV​

USD 4 billion​

Whitehorse Liquidity Partners IV​
Whitehorse Liquidity Partners IV follows a similar strategy to its predecessors, by acquiring a range of fund interests on the secondary market and targeting preferred equity investments.​
Yun Qi Partners III​

USD 300 million​

Yun Qi Partners III​
Yun Qi Partners III makes seed through series A investments in mobile internet, smart devices, and internet finance sectors.​
Zeal Capital Partners I​

USD 62.1 million​

Zeal Capital Partners I​
Zeal Capital Partners I seeks investment into high growth early stage financial services, fintech, and education companies.​
Zhuhai Abax Fund​

¥1.435 billion​

Zhuhai Abax Fund​
Zhuhai Abax Fund is a venture fund managed by Abax Global Capital. The fund invests in a diversified range of industries in China.​
True Capital III​

£$275 million​

True Capital III​
True Capital seeks to invest in UK-headquartered, lower-mid market businesses operating in the consumer products and services sector.​
STIC Global Innovative Growth Fund​
STIC Global Innovative Growth Fund​
STIC Global Innovative Growth Fund is a private growth fund managed by STIC Investments. The sector-agnostic fund plans to take minor stakes in promising sectors.​
Sofinnova Capital X​

€472 million​

Sofinnova Capital X​
Sofinnova Capital X is a venture capital fund investing into in early-stage healthcare companies in the biopharmaceutical and medical device industries in Europe.​